Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 385-389

  Doern, Gary V ^a   Jones, Ronald N ^a   Pfaller, Michael A ^a   Kugler, Kari ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; COMMUNITY CARE; DISEASE TRANSMISSION; ENZYME INHIBITION; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; UNITED STATES;

EID: 0032994953     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.385     Document Type: Article

References (30)

1. Ballow, C. H., R. N. Jones, D. M. Johnson, J. A. Deinhart, J. J. Schentag, and the SPAR Study Group. 1998. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. Diagn. Microbiol. Infect. Dis. 29:173-186.
2. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
3. Bootsma, H. J., H. van Dijk, J. Verhoef, A. Fleer, and F. R. Mooi. 1996. Molecular characterization of the BRO β-lactamase of Moraxella (Branhamella) catarrhalis. Antimicrob. Agents Chemother. 40:966-972.
4. Campos, J. M. 1995. Haemophilus, p. 556-565. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
5. Dagan, R., O. Abramson, E. Leibovitz, D. Greenberg, R. Lang, S. Goshen, P. Yagupsky, A. Leiberman, and D. M. Fliss. 1997. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J. Infect. Dis. 176:1253-1259.
6. Doern, G. V., A. B. Brueggemann, G. Pierce, H. P. Holley, Jr., and A. Rauch. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
7. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from out-patients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
8. Doern, G. V., A. B. Brueggemann, G. Pierce, T. Hogan, H. P. Holley, Jr., and A. Rauch. 1996. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:2884-2886.
9. Doern, G. V., J. H. Jorgensen, C. Thornsberry, D. A. Preston, and the Haemophilus influenzae Surveillance Group. 1986. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn. Microbiol. Infect. Dis. 4:95-107.
10. Doern, G. V., J. H. Jorgensen, C. Thornsberry, D. A. Preston, T. Tubert, J. S. Redding, and L. A. Maher. 1988. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob. Agents Chemother. 32:180-185.
11. Doern, G. V., J. H. Jorgensen, C. Thornsberry, and H. Snapper. 1990. Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium. Eur. J. Clin. Microbiol. Infect. Dis. 9:329-336.
12. Doern, G. V., M. A. Pfaller, K. Kugler, J. Freeman, and R. N. Jones. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clin. Infect. Dis., in press.
13. Doern, G. V., and T. Tubert. 1987. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents. Antimicrob. Agents Chemother. 31:1519-1523.
14. Doern, G. V., and T. Tubert. 1988. In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods. Antimicrob. Agents Chemother. 32: 259-261.
15. Doern, G. V. 1992. In vitro activity of loracarbef and effects of susceptibility test methods. Am. J. Med. 92(Suppl. 6A):6A-7S.
16. Doern, G. V. 1994. Does there exist a rational, objective in vitro basis for the management of selected infections of the respiratory tract? Infect. Dis. Clin. Pract. 3:75-80.
17. Jones, R. N., M. R. Jacobs, J. A. Washington, and M. A. Pfaller. 1997. A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States. Diagn. Microbiol. Infect. Dis. 27:75-83.
18. Jorgensen, J. H., G. V. Doern, L. A. Maher, A. W. Howell, and J. S. Redding. 1990. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob. Agents Chemother. 34:2075-2080.
19. Jorgensen, J. H., J. S. Redding, L. A. Maher, and A. W. Howell. 1987. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J. Clin. Microbiol. 25:2105-2113.
20. Knapp, J. S., and R. J. Rice. 1995. Neisseria and Branhamella, p. 324-340. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington. D.C.
21. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement M100-S8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
23. Rittenhouse, S. F., L. A. Miller, R. L. Kaplan, G. H. Mosely, and J. A. Poupard. 1995. A survey of β-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates. Diagn. Microbiol. Infect. Dis. 21:223-225.
24. Scriver, S. R., D. E. Low, A. E. Simor, B. Toye, A. McGeer, R. Jaeger, and Canadian Haemophilus Study Group. 1992. Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. J. Clin. Microbiol. 30:2284-2289.
25. Scriver, S. R., S. L. Walmsley, C. L. Kau, D. J. Hoban, J. Brunton, A. McGeer, T. C. Moore, E. Witwicki, Canadian Haemophilus Study Group, and D. E. Low. 1994. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Antimicrob. Agents Chemother. 38:1678-1680.
26. Thornsberry, C., P. H. Burton, and B. H. Vanderhoof. 1996. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study. Diagn. Microbiol. Infect. Dis. 25:89-95.
27. Tremblay, L. D., J. L'Ecuyer, P. Provencher, M. G. Bergeron, and Canadian Haemophilus Study Group. 1990. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Can. Med. Assoc. J. 143:895.
28. Wallace, R. J., Jr., D. R. Nash, and V. A. Steingrube. 1990. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am. J. Med. 88:5A-46S.
29. Wallace, R. J., Jr., V. A. Steingrube, D. R. Nash, D. G. Hollis, C. Flanagan, B. A. Brown, A. Labidi, and R. E. Weaver. 1989. BRO β-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal β-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob. Agents Chemother. 33: 1845-1854.
30. Washington, J. A., and the Alexander Project Group. 1996. A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994. The Alexander Project. Diagn. Microbiol. Infect. Dis. 25:183-190.